Clinical Trial Update: Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor stem cell transplantation after conditioning with busulfan, fludarabine, and antithymocyte globulin in patients with hematologica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Asan Medical Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED